Researchers question ethics of diabetes drug trialBMJ 2002; 325 doi: https://doi.org/10.1136/bmj.325.7360.353/a (Published 17 August 2002) Cite this as: BMJ 2002;325:353
- Ganapati Mudur
- New Delhi
Indian scientists have questioned the ethics of clinical trials of a candidate drug for diabetes conducted by the European company Novo Nordisk in 32 countries, including India, before the drugwas fully tested in animals.
Novo Nordisk suspended clinical trials of the new molecule ragaglitazar in July after it discovered that several rats and one mouse treated with the drug had developed urinary bladder tumours. The company said it was suspending the trials until the cause …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial